Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$122.88 - $144.66 $496,558 - $584,571
-4,041 Reduced 64.96%
2,180 $313,000
Q4 2023

Feb 14, 2024

SELL
$121.17 - $128.59 $361,692 - $383,841
-2,985 Reduced 32.42%
6,221 $769,000
Q3 2023

Nov 14, 2023

SELL
$112.47 - $132.89 $1.48 Million - $1.75 Million
-13,183 Reduced 58.88%
9,206 $1.15 Million
Q2 2023

Aug 14, 2023

SELL
$112.49 - $121.7 $215,980 - $233,664
-1,920 Reduced 7.9%
22,389 $2.59 Million
Q4 2022

Feb 14, 2023

BUY
$93.98 - $110.93 $2.28 Million - $2.7 Million
24,309 New
24,309 $2.67 Million

Others Institutions Holding ATR

About APTARGROUP, INC.


  • Ticker ATR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 65,337,000
  • Market Cap $11.3B
  • Description
  • AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps...
More about ATR
Track This Portfolio

Track Kerrisdale Advisers, LLC Portfolio

Follow Kerrisdale Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kerrisdale Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kerrisdale Advisers, LLC with notifications on news.